As the PI3K/Akt/mTOR signalling pathway plays a very important role in cancer therapeutic resistance including CaP [14, 15], we investigated whether this pathway is involved in the effects of EpCAM-KD on CaP xenografts using IHC. This evidence concerns the gene AKT1 and cancer.